PFM Health Sciences’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$14.2M	Buy	+266,167	New	+$14.2M	1.21%	26
2023 Q4	–	Sell	-214,298	Closed	-$10.8M	–	64
2023 Q3	$10.8M	Buy	+214,298	New	+$10.8M	0.51%	50